KCNK2 and depressive disorder: A previous study demonstrated that TREK‐1‐deficient mice displayed a depression‐resistant phenotype by increasing the efficacy of 5‐hydroxytryptamine (5‐HT) neurotransmission and reducing the elevation of corticosterone levels under stress.13